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reference fields and machine-specific reference fields. The 
sixth chapter provides the practical recommendations for the 
determination of field output factors in small photon fields. 
Comprehensive data on beam quality correction factors for 
ionization chamber types recommended for reference 
dosimetry are provided in chapter five and a detailed 
discussion on how they have been derived from the literature 
as well as a discussion of their uncertainties is given in the 
first Appendix. For beams with flattening filter (WFF beams) 
these data are consistent with the ones given in IAEA TRS-398 
and the update to AAPM TG-51. For FFF beams additional 
corrections are taken into account for the difference in water 
to air stopping power ratios between FFF and WFF beams and 
for volume averaging due to the non-uniform lateral beam 
profiles. Comprehensive data on small field correction factors 
are given in chapter six for a wide range of recommended 
small field detectors. The second Appendix discusses in detail 
how these data have been compiled from the literature 
including both Monte Carlo calculated and experimental data 
and also provides a thorough evaluation of the uncertainties 
of those data. 
The Code of Practice has been reviewed by referees selected 
by the AAPM and by the IAEA and is currently submitted for 
publication by the IAEA. This presentation is given on behalf 
of the IAEA-AAPM Working Group on small and non-standard 
field dosimetry. 
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During the last years small field dosimetry (re-)gained 
importance. Several working groups highlighted its relevance 
in the context of high precision radiotherapy techniques. 
Non-conventional linear accelerators that do not support 
standard reference geometry and the upcoming unflattened 
photon beams had an impact on upcoming recommendations 
in this context as well. However, recent audits revealed large 
uncertainties in small field dosimetry with deviations up to 
10% for 2 x 2 cm2 fields, which motivated the present 
contribution. Clinically used beam models of two TPS 
(Monaco, ELEKTA and iPlan, BrainLAB) were modified to 
mimic the large uncertainties in small field output factors. 
Next IMRT and VMAT treatment plans for prostate and head 
and neck cancer cases as well as treatment plans for 
stereotactic brain lesions were generated and calculated with 
correct and incorrect beam models, respectively. Finally, 
treatment plans were delivered with an ELEKTA Versa HD 
linac. Dose calculations were compared with measurements 
performed with EBT films and a detector array. Effects of 
uncertainties in small field output factors were less 
pronounced for IMRT and VMAT plans compared to 
stereotactic techniques delivered with static fields or 
dynamic arcs. TPS specific sequencing of IMRT and VMAT had 
an impact on the final results. The gamma evaluation 
performed with detector arrays was not able to dissolve 
uncertainties in small field dosimetry due to the rather large 
detector. On the other hand single detector signal was 
sensitive to such uncertainties. Upcoming treatment 
techniques like dose painting will use small fields more 
extensively and motivates highest accuracy in small field 
dosimetry. Published reference data and guidelines including 
detector correction factors contribute to eliminate gross 
uncertainties (>5%) in small field dosimetry. 
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The postal dose audit programme for radiotherapy dosimetry 
operated jointly by the International Atomic Energy Agency 
(IAEA) and the World Health Organization (WHO) has been in 
existence for over 45 years. To-date the calibration of over 
11300 radiotherapy beams in 2200 hospitals in 132 countries 
has been audited. Several hospitals have improved their 
dosimetry practices over the years, and the percentage of 
acceptable results is > 95% at present. The IAEA records 
suggest that regular participation in audits is associated with 
higher quality dosimetry than the first participation. It 
confirms that the dosimetry audit is useful to enhance 
confidence in radiotherapy dosimetry for both medical 
physicists and clinicians who need assurance that their 
patients receive safe and high quality radiation treatment, 
which is not possible without accurate dosimetry. However, 
with the increasing complexity of radiotherapy treatments, 
basic dosimetry audits are no longer sufficient and more 
complex audit programmes testing different dosimetry 
parameters and treatment delivery techniques are required.  
The first IAEA ‘end-to-end’ audit methodology was developed 
for 3D conformal radiotherapy. It reviewed dosimetry, 
imaging, treatment planning and radiotherapy delivery 
processes following the pathway similar to that of the patient 
undergoing radiotherapy. The audit was implemented at 
national levels with the IAEA providing an anthropomorphic 
thorax phantom (CIRS) and expert advice. National groups 
conducted the audit at local hospitals through on-site visits. 
TPS calculated doses were compared with ion chamber 
measurements for a set of test cases. In Europe, the audit 
has been carried out in 60 hospitals in 8 countries. About 200 
data sets have been collected and reviewed. Discrepancies 
requiring interventions were discovered in about 10% of 
datasets. In addition, suboptimal beam modelling in TPSs 
occurred in several centres. Overall, the audit contributed to 
better understanding of the performance of TPSs and helped 
to resolve discrepancies related to imaging, dosimetry and 
treatment planning.  
Recently, a new methodology has been developed for on-site 
‘end-to-end’ audits to review the physics aspects of head and 
neck IMRT treatments. It uses a dedicated anthropomorphic 
head and shoulders phantom (CIRS) with a set of contours 
representing the target volumes and organs at risk. The 
contours are imported and superimposed on the CT scans of 
the phantom. The treatment plan is developed and 
transferred to the treatment machine for the dose delivery. 
Ion chambers and radiochromic films are used for dose 
measurements. Comparisons are made between the TPS 
calculated and measured doses. The audit methodology is 
currently tested within an international study group.  
For >20 years the IAEA has supported the development of 
audit methodologies for national audit groups using remote 
audit tools. Current projects focus on remote IMRT audits 
involving different audit steps, e.g. small beam dosimetry 
relevant for IMRT. One study compared TPS calculated beam 
outputs to the published reference data sets. The results 
showed good agreement (within 1%) between the TPS output 
and the reference data for field sizes ≥ 4×4 cm2 and dose 
overestimation by TPSs by 2%−3% for field sizes ≤ 3×3 cm2. 
Auditing methodology was also developed to verify the TPS 
modelling of small MLC shaped beam profiles using 
radiochromic film measurements for 2×5 cm2 and a 2×2 cm2 
fields. Relative differences between the profiles at 20%, 50% 
and 80% dose levels were evaluated. Only 64% beam profiles 
were within 3 mm agreement between the TPS calculated 
and film measured doses. This highlights some limitations in 
TPS modelling of small beam profiles in the direction of MLC 
leave movements. Such differences can affect patient 
treatments, especially for stereotactic radiotherapy and 
IMRT. Another study evaluated MLC performance using picket 
fence tests and confirmed that most MLCs performed as 
expected. A comparison of gamma analysis techniques was 
also conducted through a multicentre analysis of a film 
irradiated with a complex field arrangement. Differences in 
gamma agreement occurred that were attributed to the 
differences in film scanning parameters and gamma 
calculation algorithms. A newest study on remote ‘end-to-
end’ IMRT audit is on-going. Overall, the results of these 
studies demonstrate challenges in TPS commissioning for 
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small fields and challenges in multicentre comparison of 
gamma analysis for complex dose distributions.  
Overall, the IAEA supports developments of various audit 
tools for radiotherapy with the audit scope corresponding to 
the evolving complexity of radiotherapy technology, in order 
to verify radiotherapy physics practices and improve the 
quality of treatments delivered to cancer patients in 
participating countries. 
 
Symposium: Strategies for treatment planning  
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This presentation will focus on the main differences between 
the radiotherapy treatment planning with photons and 
protons. An important issue in all treatment planning is the 
dosimetric uncertainties and margins to account for these. 
Compared to photons, protons have additional sources of 
uncertainties that should be analysed and understood. 
Insufficient quantification of margins can have more serious 
consequences in proton therapy than is the case for photons.  
The main advantage of proton beams is the finite range and 
sharp distal dose fall off in depth, an advantage that often is 
a contradiction in the sense that the range uncertainty limits 
the use of this advantage. A second advantage is the ability 
to, with every single field, give the target volume a higher 
dose than the surrounding tissue. The sources of range 
uncertainties are caused by the patient variations in anatomy 
and the uncertainties in the conversion of CT numbers to 
tissues with the correct proton interaction properties. The 
handling of range uncertainties play a critical role in proton 
planning and has an impact on the entire treatment planning 
process that differs from photons.  
The generic PTV margin recipes used in photon planning, are 
not adequate in proton planning. Primarily, this is used to 
account for lateral beam uncertainties. In proton planning, 
two margins have to be considered, the lateral and the 
margin in depth i.e. range uncertainty. In principle, these 
two margins arises from different physical processes. 
According to ICRU 78 [1] the PTVs are recommended to be 
used in proton planning for dose reporting purposes. 
Additional volumes with beam specific margins, have to be 
used to account for uncertainties in range. Paganetti has 
suggested margin recipes that is widely used in proton 
planning [2].  
Consequently, the range uncertainty also has an influence on 
the selection of beam and their entry angles. In this phase of 
the treatment planning process, proton planning emphasizes 
other considerations than photons. Robust planning has the 
potential of mitigate the impact of range uncertainties, 
aiming for a robust beam path i.e. heterogeneous geometry 
along the beam path. Likewise, the robustness should be 
considered during the optimization as well as during the 
treatment plan evaluation and the comparison with a photon 
treatment plan to choose the best treatment plan.  
The contents of this presentation are based on experiences 
from the start-up of the first Scandinavian Proton Centre, 
Skandionkliniken, where the first patients were treated in 
late august 2015. Nearly four years before that, in January 
2012, we started the Proton School in order to prepare for 
the clinical start and to train a group of medical physicists, 
dosimetrists and radiation oncologists in proton planning 
[3,4]. Thinking protons instead of photons has been the 
greatest challenge for the group as a whole. How do we 
achieve the best plan? This includes selecting robust beam 
angles and thinking about what the protons interact with on 
its way to the target volume. Discussions about target 
volumes has been frequent, as the use of them. Delineation 
is a major issue, not only for CTV/PTV but for other 
structures the protons might interact with in its beam path, 
as well as optimisation structures to provide the best 
treatment plan.  
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Anatomical changes are important issue during radiotherapy 
because they could potentially lead to inadequate dose 
distribution to target and organs at risk (OAR). Radiation 
induced complications have a significant adverse impact on 
health-related quality of life. To minimize the risk adaptive 
radiotherapy (ART) has become state of art of modern 
radiotherapy. In clinical practice ART is expressed mostly by 
Image-Guided Radiation Therapy (IGRT) and re-planning, the 
last is very individualized but should be more unified. Clear 
guidelines are therefore needed to determine the timing of 
re-planning, and an increasing amount of information needs 
to be acquainted, transferred and stored.  
There are several indications that anatomic changes are more 
pronounced in the first half of treatment, and therefore 
repeated imaging and replanning should be performed in this 
first time period.The parotid gland was the most studied OAR 
and showed the largest volume changes during radiotherapy 
(26% average volume decrease). The average number of 
radiation fractions delivered between baseline and re-
planning CT scans was 15 (±5) fractions which equals 21 (±8) 
days. It is also well established in the Head and neck (H&N) 
area that, because of i.e. weight loss and/or tumor shrinkage 
especially in more advanced stages of cancer (T3/T4, large 
N+), re-planning improves relapse–free survival and 
significantly alleviated the late effects. In many dosimetric 
studies without replanning during treatment, the doses to 
normal structures were significantly increased and doses to 
target volume significantly decreased. According to literature 
replanning frequency increases also with smaller PTV 
margins.  
To answer the question „When to re-plan?” we need to know 
which sites would most benefit. In regard to literature 
studies it seems that re-plan would be the most beneficial for 
tumors of the biggest volume or the nearest proximity of the 
OAR’s. Still it does not explain „when” should we perform it. 
Despite of the great amount of reports and analysis further 
research are needed. 
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Purpose/Objective: Labor-intensive procedures, such as 
adaptive radiotherapy, result in an increased workload in the 
treatment planning department, which can be reduced by 
introducing fully automated treatment planning. The benefits 
of automated planning are many: reduction of workload, 
increased workflow efficiency, and reduction of plan 
variability. However, a potential pitfall could be loss of 
